首页 › 基金 › Ikarian Capital, LLC › RLMD

Ikarian Capital, LLC 对 RLMD 的持仓历史

RELMADA THERAPEUTICS INC · 医疗保健

Ikarian Capital, LLC 在 Q3 2026 的 13F 申报中披露持有 RLMD(RELMADA THERAPEUTICS INC)1,448,359 股,市值约 US$5.5M,约占其申报组合的 0.80%,在其申报持仓中市值排名第 35 位。 Ikarian Capital, LLC 最近 13 个申报季度中有 13 个季度披露了 RLMD 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q3 2026)1.45M 股
申报持仓市值$5.46M
组合权重0.80%
首次申报Q3 2023
最近变动减持
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

Ikarian Capital, LLC 对 RLMD 的持仓演变

Ikarian Capital, LLC 于 Q3 2023 首次披露 RLMD 持仓:40,369 股(约 US$121K)。 该持仓在 Q1 2026 达到峰值 2,688,359 股,市值约 US$18.7M。 在 13 次申报中,Ikarian Capital, LLC 2 次增持、3 次减持、7 次保持不变。 最近一期申报(Q3 2026)显示持股 1,448,359 股、市值约 US$5.5M,环比减持 -700,000 股。。 持仓曾出现大幅变动:Q3 2025 增持约 4477% (随后一个季度股价上涨 140%)、Q4 2025 增持约 66% (随后一个季度股价上涨 44%)、Q3 2026 减持约 33% (随后一个季度股价下跌 4%)。

逐季持仓明细

季度股数金额变化
Q3 2023 40.37K $121.11K 新进
Q4 2023 40.37K $167.13K 持有
Q1 2024 40.37K $187.72K 持有
Q2 2024 40.37K $121.11K 持有
Q3 2024 40.37K $130.79K 持有
Q4 2024 40.27K $20.94K 持有
Q1 2025 40.27K $10.87K 持有
Q2 2025 40.27K $24.17K 持有
Q3 2025 1.84M $3.70M 增持
Q4 2025 3.07M $14.82M 增持
Q1 2026 2.69M $18.71M 减持
Q2 2026 2.15M $14.87M 减持
Q3 2026 1.45M $5.46M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 RLMD 与 13F 数据

RLMD(RELMADA THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 62 只申报持有 RLMD,申报仓位最大的包括:Venrock Adviser, LLC (US$28.1M), Spruce Street Capital LP (US$26.1M), Jones Hill Capital LP (US$19.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 RLMD 的基金

查看 RLMD 的全部基金持有人 →

常见问题

How long has Ikarian Capital, LLC held RLMD?

Ikarian Capital, LLC has disclosed RLMD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Ikarian Capital, LLC's current position in RLMD?

As of Q3 2026, Ikarian Capital, LLC holds 1.45M shares of RLMD (RELMADA THERAPEUTICS INC), valued at $5.46M, representing 0.80% of its reported portfolio and ranking #35.

Has Ikarian Capital, LLC been buying or selling RLMD?

In the latest 13F filing (Q3 2026), Ikarian Capital, LLC reduced its position in RLMD. The position peaked in Q1 2026 at 2.69M shares.

Which other funds hold RLMD?

Other major institutional holders of RLMD include Venrock Adviser, LLC, Spruce Street Capital LP, Jones Hill Capital LP, among 62 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.